Oh Youn Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oh Youn Kim has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Yong Song Gho
Department of Life Sciences, POSTECH, Pohang, 37673, Republic of Korea
3 shared publications Changjin Lee
Department of Life Sciences Pohang University of Science and Technology (POSTECH) Pohang Republic of Korea
1 shared publicationHyun Taek Park
Department of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea
1 shared publicationJaemin Lee
Department of Life Sciences Pohang University of Science and Technology (POSTECH) Pohang Republic of Korea
1 shared publicationJaewook Lee
Department of Life Sciences, Pohang University of Science and Technology, Pohang, 37673, Republic of Korea
1 shared publication- Jaewook Lee
Department of Mechanical and Manufacturing Engineering, University of Calgary, Calgary, Canada
1 shared publication
Latest Publications
- Open Access
- 11 August 2021
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 10 (10) , e12133
Extracellular vesicles from in vivo liver tissue accelerate recovery of liver necrosis induced by carbon tetrachloride
Extracellular vesicles (EVs) are nano‐sized vesicles composed of proteolipid bilayers carrying various molecular signatures of the cells. As mediators of intercellular communications, EVs have gained great attention as new therapeutic agents in the field of nanomedicine. Therefore, many studies have explored the roles of cell‐derived EVs isolated from cultured hepatocytes or stem cells as inducer of liver proliferation and regeneration under various pathological circumstances. However, study investigating the role of EVs directly isolated from liver tissue has not been performed. Herein, to understand the pathophysiological role and to investigate the therapeutic potential of in vivo liver EVs, we isolated EVs from both normal and carbon tetrachloride (CCl4)‐induced damaged in vivo liver tissues. The in vivo EVs purified from liver tissues display typical features of EVs including spherical morphology, nano‐size, and enrichment of tetraspanins. Interestingly, administration of both normal and damaged liver EVs significantly accelerated the recovery of liver tissue from CCl4‐induced hepatic necrosis. This restorative action was through the induction of hepatocyte growth factor at the site of the injury. These results suggest that not only normal liver EVs but also damaged liver EVs play important pathophysiological roles of maintaining homeostasis after tissue damage. Our study, therefore, provides new insight into potentially developing in vivo EV‐based therapeutics for preventing and treating liver diseases.
- 11 August 2021
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 10 (10) , e12133
Open AccessExtracellular vesicles from in vivo liver tissue accelerate recovery of liver necrosis induced by carbon tetrachloride
Extracellular vesicles (EVs) are nano‐sized vesicles composed of proteolipid bilayers carrying various molecular signatures of the cells. As mediators of intercellular communications, EVs have gained great attention as new therapeutic agents in the field of nanomedicine. Therefore, many studies have explored the roles of cell‐derived EVs isolated from cultured hepatocytes or stem cells as inducer of liver proliferation and regeneration under various pathological circumstances. However, study investigating the role of EVs directly isolated from liver tissue has not been performed. Herein, to understand the pathophysiological role and to investigate the therapeutic potential of in vivo liver EVs, we isolated EVs from both normal and carbon tetrachloride (CCl4)‐induced damaged in vivo liver tissues. The in vivo EVs purified from liver tissues display typical features of EVs including spherical morphology, nano‐size, and enrichment of tetraspanins. Interestingly, administration of both normal and damaged liver EVs significantly accelerated the recovery of liver tissue from CCl4‐induced hepatic necrosis. This restorative action was through the induction of hepatocyte growth factor at the site of the injury. These results suggest that not only normal liver EVs but also damaged liver EVs play important pathophysiological roles of maintaining homeostasis after tissue damage. Our study, therefore, provides new insight into potentially developing in vivo EV‐based therapeutics for preventing and treating liver diseases.
- Top Cited PapersOpen Access
- 20 September 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-9
Bacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response
Gram-negative bacteria actively secrete outer membrane vesicles, spherical nano-meter-sized proteolipids enriched with outer membrane proteins, to the surroundings. Outer membrane vesicles have gained wide interests as non-living complex vaccines or delivery vehicles. However, no study has used outer membrane vesicles in treating cancer thus far. Here we investigate the potential of bacterial outer membrane vesicles as therapeutic agents to treat cancer via immunotherapy. Our results show remarkable capability of bacterial outer membrane vesicles to effectively induce long-term antitumor immune responses that can fully eradicate established tumors without notable adverse effects. Moreover, systematically administered bacterial outer membrane vesicles specifically target and accumulate in the tumor tissue, and subsequently induce the production of antitumor cytokines CXCL10 and interferon-γ. This antitumor effect is interferon-γ dependent, as interferon-γ-deficient mice could not induce such outer membrane vesicle-mediated immune response. Together, our results herein demonstrate the potential of bacterial outer membrane vesicles as effective immunotherapeutic agent that can treat various cancers without apparent adverse effects.
- 20 September 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-9
Top Cited PapersOpen AccessBacterial outer membrane vesicles suppress tumor by interferon-γ-mediated antitumor response
Gram-negative bacteria actively secrete outer membrane vesicles, spherical nano-meter-sized proteolipids enriched with outer membrane proteins, to the surroundings. Outer membrane vesicles have gained wide interests as non-living complex vaccines or delivery vehicles. However, no study has used outer membrane vesicles in treating cancer thus far. Here we investigate the potential of bacterial outer membrane vesicles as therapeutic agents to treat cancer via immunotherapy. Our results show remarkable capability of bacterial outer membrane vesicles to effectively induce long-term antitumor immune responses that can fully eradicate established tumors without notable adverse effects. Moreover, systematically administered bacterial outer membrane vesicles specifically target and accumulate in the tumor tissue, and subsequently induce the production of antitumor cytokines CXCL10 and interferon-γ. This antitumor effect is interferon-γ dependent, as interferon-γ-deficient mice could not induce such outer membrane vesicle-mediated immune response. Together, our results herein demonstrate the potential of bacterial outer membrane vesicles as effective immunotherapeutic agent that can treat various cancers without apparent adverse effects.
- 10 October 2016
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 10 (9-10)
Front cover: Proteomic profiling of Gram‐negative bacterial outer membrane vesicles: Current perspectives
- 10 October 2016
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 10 (9-10)
Front cover: Proteomic profiling of Gram‐negative bacterial outer membrane vesicles: Current perspectives